HilleVax (HLVX) Competitors $2.09 0.00 (0.00%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$2.09 0.00 (0.00%) As of 09/12/2025 06:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HLVX vs. KMDA, CGEM, AURA, PRTC, FULC, SLDB, YMAB, MBX, IMAB, and DMACShould you be buying HilleVax stock or one of its competitors? The main competitors of HilleVax include Kamada (KMDA), Cullinan Therapeutics (CGEM), Aura Biosciences (AURA), PureTech Health (PRTC), Fulcrum Therapeutics (FULC), Solid Biosciences (SLDB), Y-mAbs Therapeutics (YMAB), MBX Biosciences (MBX), I-Mab (IMAB), and DiaMedica Therapeutics (DMAC). These companies are all part of the "pharmaceutical products" industry. HilleVax vs. Its Competitors Kamada Cullinan Therapeutics Aura Biosciences PureTech Health Fulcrum Therapeutics Solid Biosciences Y-mAbs Therapeutics MBX Biosciences I-Mab DiaMedica Therapeutics HilleVax (NASDAQ:HLVX) and Kamada (NASDAQ:KMDA) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, institutional ownership, earnings, profitability, valuation and risk. Which has preferable valuation and earnings, HLVX or KMDA? Kamada has higher revenue and earnings than HilleVax. HilleVax is trading at a lower price-to-earnings ratio than Kamada, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHilleVaxN/AN/A-$147.27M-$1.43-1.46Kamada$160.95M2.51$14.46M$0.3420.65 Is HLVX or KMDA more profitable? Kamada has a net margin of 11.22% compared to HilleVax's net margin of 0.00%. Kamada's return on equity of 7.41% beat HilleVax's return on equity.Company Net Margins Return on Equity Return on Assets HilleVaxN/A -34.29% -28.50% Kamada 11.22%7.41%5.18% Which has more risk & volatility, HLVX or KMDA? HilleVax has a beta of 0.77, meaning that its stock price is 23% less volatile than the S&P 500. Comparatively, Kamada has a beta of 0.89, meaning that its stock price is 11% less volatile than the S&P 500. Do insiders and institutionals hold more shares of HLVX or KMDA? 86.4% of HilleVax shares are held by institutional investors. Comparatively, 20.4% of Kamada shares are held by institutional investors. 24.9% of HilleVax shares are held by insiders. Comparatively, 36.1% of Kamada shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Do analysts recommend HLVX or KMDA? HilleVax presently has a consensus price target of $2.00, suggesting a potential downside of 4.31%. Kamada has a consensus price target of $13.00, suggesting a potential upside of 85.19%. Given Kamada's stronger consensus rating and higher possible upside, analysts clearly believe Kamada is more favorable than HilleVax.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HilleVax 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Kamada 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Does the media prefer HLVX or KMDA? In the previous week, Kamada had 1 more articles in the media than HilleVax. MarketBeat recorded 3 mentions for Kamada and 2 mentions for HilleVax. Kamada's average media sentiment score of 1.47 beat HilleVax's score of 0.45 indicating that Kamada is being referred to more favorably in the news media. Company Overall Sentiment HilleVax Neutral Kamada Positive SummaryKamada beats HilleVax on 14 of the 15 factors compared between the two stocks. Get HilleVax News Delivered to You Automatically Sign up to receive the latest news and ratings for HLVX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HLVX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HLVX vs. The Competition Export to ExcelMetricHilleVaxMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$104.79M$3.20B$5.87B$10.13BDividend YieldN/A2.30%5.68%4.60%P/E Ratio-1.4621.1774.5225.93Price / SalesN/A427.59516.43181.21Price / CashN/A46.6837.5660.44Price / Book0.679.6112.166.29Net Income-$147.27M-$53.29M$3.28B$270.77M7 Day Performance-0.48%0.12%0.78%3.84%1 Month Performance0.97%5.60%4.87%4.85%1 Year Performance14.21%10.47%60.72%26.00% HilleVax Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HLVXHilleVax1.5971 of 5 stars$2.09flat$2.00-4.3%+20.8%$104.79MN/A-1.4620Short Interest ↑KMDAKamada4.4742 of 5 stars$7.19-0.5%$13.00+80.9%+29.5%$413.17M$169.52M21.13360Short Interest ↓CGEMCullinan Therapeutics2.2087 of 5 stars$6.92+1.2%$26.80+287.3%-62.9%$409.24MN/A-2.1430News CoverageAnalyst ForecastAURAAura Biosciences2.2678 of 5 stars$6.47flat$22.00+240.0%-36.9%$402.29MN/A-3.3050Positive NewsPRTCPureTech Health0.5658 of 5 stars$16.61+1.1%N/A-21.2%$400.83M$6.17M0.00100Short Interest ↑FULCFulcrum Therapeutics2.6324 of 5 stars$7.31+0.6%$7.57+3.6%+103.5%$395.40M$80M-5.99100News CoveragePositive NewsShort Interest ↓SLDBSolid Biosciences3.0042 of 5 stars$5.02-2.1%$15.00+198.8%-30.2%$391.30M$8.09M-1.79100Positive NewsAnalyst DowngradeYMABY-mAbs Therapeutics2.0888 of 5 stars$8.59-0.1%$9.62+12.1%-35.1%$390.10M$87.68M-17.17150News CoveragePositive NewsMBXMBX Biosciences0.1348 of 5 stars$11.35+4.1%N/AN/A$381.29MN/A-2.50N/ANews CoverageAnalyst UpgradeIMABI-Mab2.7945 of 5 stars$4.57+7.0%$7.00+53.2%+293.3%$373.27M$3.89M0.00380Analyst ForecastGap UpDMACDiaMedica Therapeutics2.2293 of 5 stars$7.16flat$12.33+72.3%+65.3%$372.17MN/A-10.4320Positive NewsAnalyst Upgrade Related Companies and Tools Related Companies KMDA Competitors CGEM Competitors AURA Competitors PRTC Competitors FULC Competitors SLDB Competitors YMAB Competitors MBX Competitors IMAB Competitors DMAC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HLVX) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HilleVax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HilleVax With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HLVX Stock Alerts